JP2017524143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524143A5 JP2017524143A5 JP2017510438A JP2017510438A JP2017524143A5 JP 2017524143 A5 JP2017524143 A5 JP 2017524143A5 JP 2017510438 A JP2017510438 A JP 2017510438A JP 2017510438 A JP2017510438 A JP 2017510438A JP 2017524143 A5 JP2017524143 A5 JP 2017524143A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- schizophrenia
- loss
- disorder
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020035496A JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461986480P | 2014-04-30 | 2014-04-30 | |
| US61/986,480 | 2014-04-30 | ||
| PCT/US2015/028385 WO2015168346A1 (en) | 2014-04-30 | 2015-04-30 | Use of known compounds as d-amino acid oxidase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020035496A Division JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017524143A JP2017524143A (ja) | 2017-08-24 |
| JP2017524143A5 true JP2017524143A5 (cg-RX-API-DMAC10.html) | 2018-06-14 |
Family
ID=54359315
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510438A Pending JP2017524143A (ja) | 2014-04-30 | 2015-04-30 | Ｄ−アミノ酸オキシダーゼ阻害剤としての既知の化合物の使用 |
| JP2020035496A Active JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020035496A Active JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Country Status (15)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202102125SA (en) * | 2014-04-30 | 2021-04-29 | Yufeng Tseng | Use of known compounds as d-amino acid oxidase inhibitors |
| EP4289425A3 (en) | 2016-09-14 | 2024-08-07 | Yufeng Jane Tseng | Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors |
| CN108143734A (zh) * | 2018-02-09 | 2018-06-12 | 南京中医药大学 | 阿莫地喹及其药学上可接受的盐在制备用于治疗阿尔茨海默病的药物中的应用 |
| US20220016099A1 (en) * | 2018-12-06 | 2022-01-20 | Trinuero | Benzimidazole or benzoxazole derivatives for preventing and treating central nervous system disease, diabetes, and complications thereof |
| CA3127607A1 (en) * | 2019-01-23 | 2020-07-30 | The Regents Of The University Of Michigan | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
| CN110297839B (zh) * | 2019-06-25 | 2022-04-12 | 中国人民解放军军事科学院军事医学研究院 | 药物适应症的查询方法、装置、计算机设备和存储介质 |
| MX2026004033A (es) * | 2021-06-23 | 2026-05-04 | Yoda Therapeutics Inc | Derivados del benzimidazol para el tratamiento y/o la prevencion de enfermedades y trastornos mediados por el nlrp3 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619652A (en) | 1982-12-23 | 1986-10-28 | Alza Corporation | Dosage form for use in a body mounted pump |
| PT93943A (pt) | 1989-05-05 | 1991-02-08 | Searle & Co | Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc |
| GB9208492D0 (en) | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| GB9304500D0 (en) | 1993-03-05 | 1993-04-21 | Glaxo Spa | Heterocyclic compounds |
| GB9321221D0 (en) | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
| ATE455083T1 (de) * | 1995-11-13 | 2010-01-15 | Akiko Itai | Verfahren zum entwurf einer physiologisch aktiven verbindung |
| MXPA03005130A (es) * | 2000-12-07 | 2004-12-06 | Neuromolecular Inc | Metodos para tratar trastornos neurosiquiatricos con antagonistas del receptor del nmda. |
| WO2003039540A2 (en) | 2001-11-09 | 2003-05-15 | Sepracor Inc. | D-amino acid oxidase inhibitors for learning and memory |
| WO2003097011A1 (en) * | 2002-05-17 | 2003-11-27 | Eisai Co., Ltd. | Compositions and methods using proton pump inhibitors |
| WO2005089753A2 (en) | 2004-03-16 | 2005-09-29 | Janssen Pharmaceutica N.V. | Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders |
| ATE425791T1 (de) * | 2005-07-29 | 2009-04-15 | Rottapharm Spa | Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheiten |
| US20090306169A1 (en) * | 2005-10-06 | 2009-12-10 | Brandish Philip E | Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors |
| US7960544B2 (en) * | 2005-12-16 | 2011-06-14 | Ironwood Pharmaceuticals, Inc. | Useful indole compounds |
| AU2007249348C1 (en) * | 2006-05-10 | 2013-01-17 | Laclede, Inc. | Compositions and methods for enzymatic treatment of lung disorders |
| KR20090024823A (ko) * | 2006-06-30 | 2009-03-09 | 세프라코 아이엔시. | Ｄ-아미노산 옥시다제의 융합된 헤테로사이클 억제제 |
| US20090099248A1 (en) * | 2007-01-18 | 2009-04-16 | Sepracor Inc. | Inhibitors of d-amino acid oxidase |
| US20120149743A9 (en) * | 2008-06-02 | 2012-06-14 | Ironwood Pharmaceuticals, Inc | Selenophene and Selenazole Carboxylic Acid Derivatives |
| JP4462382B1 (ja) * | 2009-04-23 | 2010-05-12 | 学校法人北里研究所 | Ｄ−アスパラギン酸オキシダーゼおよびｄ−アミノ酸オキシダーゼに対する新規阻害剤 |
| US20120035156A1 (en) * | 2010-08-09 | 2012-02-09 | Daniela Alberati | Combination of glyt1 compound with antipsychotics |
| JO3115B1 (ar) * | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| WO2013061161A2 (en) * | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
| KR101348984B1 (ko) * | 2012-01-31 | 2014-01-10 | 전남대학교산학협력단 | 박테리아 시토크롬 ｐ450을 이용한 오메프라졸로부터 대사산물의 신규한 생산방법 및 이를 위한 조성물 |
| SG10202102125SA (en) * | 2014-04-30 | 2021-04-29 | Yufeng Tseng | Use of known compounds as d-amino acid oxidase inhibitors |
-
2015
- 2015-04-30 SG SG10202102125SA patent/SG10202102125SA/en unknown
- 2015-04-30 IL IL248567A patent/IL248567B/en unknown
- 2015-04-30 KR KR1020167032409A patent/KR20160147868A/ko not_active Ceased
- 2015-04-30 CA CA2946153A patent/CA2946153C/en active Active
- 2015-04-30 TW TW104114104A patent/TWI675660B/zh active
- 2015-04-30 ES ES19150604T patent/ES2951736T3/es active Active
- 2015-04-30 WO PCT/US2015/028385 patent/WO2015168346A1/en not_active Ceased
- 2015-04-30 KR KR1020227029414A patent/KR102537686B1/ko active Active
- 2015-04-30 PT PT157866112T patent/PT3137658T/pt unknown
- 2015-04-30 US US16/401,892 patent/USRE49340E1/en active Active
- 2015-04-30 CN CN202011486413.7A patent/CN112773798B/zh active Active
- 2015-04-30 US US15/125,716 patent/US9868975B2/en not_active Ceased
- 2015-04-30 SG SG11201607166XA patent/SG11201607166XA/en unknown
- 2015-04-30 DK DK15786611.2T patent/DK3137658T3/da active
- 2015-04-30 EP EP19150604.7A patent/EP3498275B1/en active Active
- 2015-04-30 AU AU2015253099A patent/AU2015253099B2/en active Active
- 2015-04-30 EP EP15786611.2A patent/EP3137658B1/en active Active
- 2015-04-30 JP JP2017510438A patent/JP2017524143A/ja active Pending
- 2015-04-30 ES ES15786611T patent/ES2911879T3/es active Active
- 2015-04-30 MX MX2016011551A patent/MX2016011551A/es unknown
- 2015-04-30 CN CN201580021632.9A patent/CN106687626B/zh active Active
-
2016
- 2016-09-06 MX MX2021000133A patent/MX2021000133A/es unknown
-
2020
- 2020-03-03 JP JP2020035496A patent/JP6941326B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Brien et al. | Vascular risk factors and Alzheimer’s disease | |
| EP4548918A3 (en) | Tricyclic compounds as inhibitors of kras | |
| Laske | Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. | |
| FI3618875T3 (fi) | Raf-inhibiittoria ja trametinibia käsittävä yhdistelmähoito | |
| MX2022011518A (es) | Metodos para tratar deambulacion asociada a proteinopatia. | |
| JP2017517548A5 (cg-RX-API-DMAC10.html) | ||
| EP4218754A3 (en) | Methods of treatment for cystic fibrosis | |
| WO2016106331A8 (en) | Mutant idh1 inhibitors useful for treating cancer | |
| JP2016538257A5 (cg-RX-API-DMAC10.html) | ||
| JP2019511460A5 (cg-RX-API-DMAC10.html) | ||
| CN108463219B (zh) | 用于治疗化学治疗引起的周围神经病变的用途的il-8抑制剂 | |
| JP2015535247A5 (cg-RX-API-DMAC10.html) | ||
| EA202190586A1 (ru) | N-замещенные диоксоциклобутениламино-3-гидроксипиколинамиды, приемлемые в качестве ингибиторов ccr6 | |
| JP2016512198A5 (cg-RX-API-DMAC10.html) | ||
| ATE444077T1 (de) | Präventiva und therapeutika für mit demyelinisierung-assozierten erkrankungen | |
| EA202090194A1 (ru) | Композиции статинов и способы их применения при лечении синуклеинопатий | |
| EA200501425A1 (ru) | Арилвинилазациклоалкановые соединения и способы их получения и применения | |
| IL273922B2 (en) | D-amino acid oxidase inhibitors and therapeutic uses thereof | |
| Ashvin et al. | Unraveling the immune puzzle: Role of immunomodulation in Alzheimer’s disease | |
| EP2131837B1 (en) | Specific 3-heteroaryl-3-hydroxy-2-amino-propionic acid amide derivative for use in the treatment of certain cognitive disorders | |
| WO2018158150A1 (en) | Treatment of dementia with cannabinoid agonists | |
| US20210046064A1 (en) | Treatment of Neurodegenerative Conditions by Disruption of Rhes | |
| JP6483627B2 (ja) | 脳内アミロイドβ蓄積症の予防または治療剤 | |
| Retinasamy et al. | Aducanumab for Alzheimer's disease: An update | |
| US11571396B2 (en) | Ketamine for treatment of ADNP syndrome and sensory processing deficits |